| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.099 | 0.02 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |